Document is current

Article History

Accepted: 1 November 2023

First Online: 16 January 2024

Compliance with Ethical Standards

:

: Dr. Posas has received personal compensation for serving as a consultant for Abbvie. Reports no relevance to this manuscript. Dr. Charleston has received personal compensation for serving as a consultant for Allergan/AbbVie, Amgen, Amneal, Aurene Corporation/eNeura, Biohaven, Haleon, LinPharma, Pfizer, Satsuma and Teva; was on the advisory panel for Ctrl M Health (stock-defunct); received grant/research support from the Disparities in Headache Advisory Council and Amgen. He has received CME honoraria from American Headache Society, American Academy of Neurology, BrainWeekend, Migraine360 CME Program, NeurologyWeek, and the Primary Care Education Consortium. He receives a salary as faculty from Michigan State University College of Human Medicine and Thomas Jefferson University. He is a non-compensated associate editor for <i>Headache</i>: The Journal of Head and Face Pain and serves as a non-compensated Board Member-at-Large for the Clinical Neurological Society of America. Reports no relevance to this manuscript.

: This article does not contain any studies with human or animal subjects performed by any of the authors.